QIVA COSMETICS / INSIGHTS & EXPERTISE

How a skincare idea becomes a carefully developed, tested and documented cosmetic product — and why the work you do not see matters just as much as what is inside the bottle.

At QIVA Cosmetics, we believe a successful product begins long before the first ingredient is weighed. Thoughtful formulation combines consumer needs, ingredient science, manufacturing discipline, quality control and regulatory responsibility. For brand owners, understanding that journey helps explain why professional product development requires time, expertise and evidence.

1. It starts with a clear product brief

First, we define what the product must achieve and who it is intended for. Is it a lightweight facial serum, a rich body cream, a gentle children’s wash or a leave-on treatment? Intended users, application area, sensory preferences, packaging, price positioning, claims and target markets all influence development from the beginning.

A good brief distinguishes desirable marketing features from requirements that can actually be demonstrated. “Gentle”, “suitable for sensitive skin”, “vegan” and performance-related statements should be supported by appropriate formulation choices, documentation and, where needed, testing. A product for very young children or for use around the eyes demands particular attention during safety assessment.

2. Choosing ingredients for a purpose — not a trend

Every ingredient needs a reason to be present. Humectants help attract moisture; emollients influence comfort and skin feel; emulsifiers allow otherwise incompatible phases to form a stable system; thickeners define flow and texture; and preservatives help protect susceptible products from microbial contamination. Their interactions matter as much as their individual functions.

We evaluate the intended function, supplier specifications, material quality, impurity profile, compatibility, stability, concentration, skin exposure and applicable restrictions. Suppliers may provide technical data sheets, safety data sheets, certificates of analysis and supporting evidence. INCI names support transparent labelling, but the INCI list alone does not describe a formula’s safety or performance.

A compelling ingredient story never replaces a responsible safety review. “Natural” does not automatically mean safer, and sophisticated formulation is about finding the right balance — not adding the longest possible list of fashionable actives.

3. The hidden importance of water quality

Water is often a major component of a skincare product, yet it must never be treated as an insignificant raw material. Water used in cosmetics needs quality specifications appropriate to its intended use, a suitable treatment and distribution arrangement, monitoring and records. These controls may cover conductivity or other chemical indicators and microbiological quality, depending on the system and risk assessment.

Purification technologies can include reverse osmosis, deionisation and ultraviolet treatment. No single conductivity number or purification method guarantees microbiological safety. Hygienic storage, maintenance, sampling, defined acceptance criteria and appropriate corrective action are equally important. At QIVA, we consider water quality part of the manufacturing quality system rather than simply a utility.

4. Preparation, identification and accurate weighing

Before a batch begins, materials must be correctly identified, checked against their approved specifications and released for use according to the applicable procedure. Weighing takes place with appropriate scales, suitable containers, clean utensils, controlled documentation and trained personnel. Equipment condition, calibration or verification status, ingredient identity, lot numbers and actual quantities should be traceable.

Materials may be prepared separately according to the approved manufacturing instructions. Where needed, water-soluble and oil-soluble materials are handled in different phases, while sensitive ingredients may require later addition. These are principles of controlled processing, not a universal formula: exact sequence, temperatures, mixing parameters and proportions depend on each product and are retained in its controlled manufacturing documentation.

5. A controlled environment and repeatable manufacturing

Consistent quality depends on a suitable manufacturing environment. Room and equipment cleanliness, personnel hygiene, protective clothing where appropriate, pest prevention, material flow, equipment maintenance and prevention of cross-contamination are considered within Good Manufacturing Practice (GMP). Facilities and controls are adapted to the products and risks involved; a cosmetic production room should not be described as sterile unless a validated sterile process genuinely applies.

During manufacturing, teams follow approved instructions and document critical activities. Depending on the formula, a process may include controlled mixing, emulsification, cooling, adjustments, in-process sampling and transfer to filling. Results such as appearance, pH or viscosity may be checked at defined points. Traceable batch records help demonstrate what was done, with which materials and equipment, and by whom.

6. The tests behind a finished product

A promising first sample is only the beginning. The exact test programme is risk-based and tailored to the formulation, packaging, intended use and available evidence. Typical development and release controls may include:

· Physical and chemical assessment — appearance, odour, pH (where relevant), viscosity and other suitable specifications.

· Stability studies — assessing behaviour over time and under relevant storage, transport or stress conditions, including separation, discoloration or changes in performance.

· Microbiological quality testing — evaluating microbial contamination against appropriate specifications.

· Preservative efficacy / challenge testing — assessing antimicrobial protection when indicated by the microbiological risk assessment; ISO 11930 provides a recognised framework.

· Packaging compatibility — checking whether the formula and container affect each other, including dispensing performance, leakage and relevant material interactions.

· Additional substantiation — targeted studies to support specific claims, if claims are made.

Not every test is universally mandatory for every formulation, and a single satisfactory laboratory result does not replace a complete safety assessment. Products with very low microbiological risk can have different testing needs from water-based products frequently exposed during use. Deviations or failed acceptance criteria should trigger investigation and, where appropriate, reformulation or further testing.

7. Packaging is part of the formulation strategy

A great formula in the wrong bottle can still become a poor product. Pump, jar, tube and airless packaging differ in user exposure, filling behaviour, oxygen contact, dispensing and compatibility. We consider pack size, material suitability, labelling area, transportation and the consumer experience when selecting a solution.

Packaging should be assessed alongside the formula rather than left until the last moment. Even a change of container, application method or material may require reconsideration of compatibility, safety evidence or relevant documentation.

8. European regulatory readiness: more than a label

For cosmetic products placed on the EU market, Regulation (EC) No 1223/2009 establishes the core framework. Before marketing, the designated Responsible Person must ensure that a qualified safety assessor prepares the Cosmetic Product Safety Report (CPSR), the Product Information File (PIF) is maintained, and the required notification is submitted through the Cosmetic Products Notification Portal (CPNP). CPNP is a notification system — not a government product approval or certification.

Manufacture must follow GMP principles; ISO 22716 is the widely used cosmetics GMP guideline. Labels must contain the required particulars, and ingredient restrictions, claims rules and other applicable obligations must be respected. The PIF includes, among other elements, safety and manufacturing/GMP information and must be kept for the required period. Requirements outside the EU, including mainland China, must be assessed separately and cannot be assumed to be identical.

9. From development sample to consistent production

When the formula is finalised and the evidence is sufficient, the next challenge is repeatability. Scaling up requires careful control because a lab sample and a manufacturing batch may not behave identically. Approved specifications, trained operators, documented controls, raw-material traceability and defined release decisions help protect the quality of successive batches.

Quality is not something inspected into a product at the end. It is built into the decisions made throughout its lifecycle — from the initial brief and supplier evaluation through manufacturing, testing, documentation and ongoing review.

The QIVA Cosmetics approach

We combine practical manufacturing knowledge with a quality-first development mindset. Our aim is to help ambitious brands turn ideas into thoughtfully engineered cosmetic products, supported by clear communication, appropriate testing and responsible production practices. We believe good partnerships are built on transparency about what is required, what must be demonstrated and what a realistic development programme involves.

Developing a new skincare or body-care line? Talk to QIVA Cosmetics about formulation development, private-label manufacturing and the route from concept to production.

Explore QIVA Cosmetics at qiva.se

Reference framework

EU Cosmetic Products Regulation (EC) No 1223/2009; Commission Decision 2013/674/EU on cosmetic safety assessment; ISO 22716 (cosmetic GMP); ISO 11930:2019 (evaluation of antimicrobial protection). Specific requirements and current substance restrictions should be verified for each product and market.

Editorial note: This article describes general industry principles and the QIVA quality philosophy. It does not disclose individual product formulas, confidential production parameters or proprietary process instructions.